These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3274919)

  • 1. Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profiles.
    Palmer GC; Ordy JM; Simmons RD; Strand JC; Mullen GB; Kinsolving CR; St Georgiev V; Allen SD
    Ann N Y Acad Sci; 1988; 544():387-91. PubMed ID: 3274919
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antifungal activity of novel isoxazolidine compounds.
    Mullen GB; Swift PA; Bennett GA; DeCory TR; Maryniak DM; Dormer PG; St Georgiev V
    Ann N Y Acad Sci; 1988; 544():32-45. PubMed ID: 3214072
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles.
    Palmer GC; Ordy MJ; Simmons RD; Strand JC; Radov LA; Mullen GB; Kinsolving CR; St Georgiev V; Mitchell JT; Allen SD
    Antimicrob Agents Chemother; 1989 Jun; 33(6):895-905. PubMed ID: 2764540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
    Zhang H; Wang K; Zhang G; Ho HI; Gao A
    Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis.
    Sobel JD; Muller G
    Antimicrob Agents Chemother; 1984 Aug; 26(2):266-7. PubMed ID: 6091538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole resistance in Candida albicans.
    Ryley JF; Wilson RG; Barrett-Bee KJ
    Sabouraudia; 1984; 22(1):53-63. PubMed ID: 6322363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nizoral - an effective and affordable drug to treat vaginal candidiasis ].
    Nikolov A
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():44-7. PubMed ID: 20387276
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
    Sobel JD; Muller G
    Antimicrob Agents Chemother; 1983 Sep; 24(3):434-6. PubMed ID: 6314893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology.
    Peeters F; Snauwaert R; Segers J; Van Cutsem J; Amery W
    Arzneimittelforschung; 1973 Aug; 23(8):1107-11. PubMed ID: 4588098
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
    Ichise K; Tanio T; Saji I; Okuda T
    Antimicrob Agents Chemother; 1986 Sep; 30(3):366-9. PubMed ID: 3777903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
    Sobel JD
    Obstet Gynecol; 1985 Mar; 65(3):435-40. PubMed ID: 3838374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives.
    Mullen GB; DeCory TR; Mitchell JT; Allen SD; Kinsolving CR; Georgiev VS
    J Med Chem; 1988 Oct; 31(10):2008-14. PubMed ID: 3172137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis.
    de Freitas Araújo MG; Pacífico M; Vilegas W; Dos Santos LC; Icely PA; Miró MS; Scarpa MV; Bauab TM; Sotomayor CE
    Med Mycol; 2013 Oct; 51(7):673-82. PubMed ID: 23758104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of Nifuratel on lower genital infections].
    Fayette M
    J Med Lyon; 1971 Nov; 52(216):1445-51. PubMed ID: 5124554
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis.
    Rohde-Werner H
    J Int Med Res; 1984; 12(5):298-302. PubMed ID: 6094282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract]   [Full Text] [Related]  

  • 18. Sertaconazole: pharmacology of a gynecological antifungal agent.
    Palacín C; Tarragó C; Ortiz JA
    Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S37-46. PubMed ID: 11118563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole in experimental vaginal candidosis in rats.
    Kinsman OS; Collard AE; Savage TJ
    Antimicrob Agents Chemother; 1986 Nov; 30(5):771-3. PubMed ID: 3800354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of pregnancy infections caused by monilia and Trichomonas with nifuratel].
    Chamma Neto M; Teixeira RM
    Rev Bras Med; 1969 Oct; 26(10):599-601. PubMed ID: 5404869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.